Chinese Medical Journal (Jun 2024)
SGLT2 inhibitor monotherapy alleviates hyperglycemia in heredity severe insulin resistance syndrome
- Huixuan Wu,
- Junaid Iqbal,
- Long Li,
- Hongli Jiang,
- Chen Chao,
- Meibiao Zhang,
- Ou Li,
- Houde Zhou,
- Jing Ni,
- Xuehong Zhang
Affiliations
- Huixuan Wu
- 1 Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
- Junaid Iqbal
- 1 Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
- Long Li
- 1 Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
- Hongli Jiang
- 1 Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
- Chen Chao
- 1 Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
- Meibiao Zhang
- 2 Department of Endocrinology and Metabolism, The First People’s Hospital of Huaihua, Huaihua, Hunan 418000, China
- Ou Li
- 3 Department of Metabolism and Endocrinology, San-Sui County Traditional Chinese Medicine Hospital, Qiandongnan Miao and Dong Autonomous Prefecture, Guizhou 556000, China
- Houde Zhou
- 1 Department of Metabolism and Endocrinology, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Key Laboratory for Metabolic Bone Diseases, Key Laboratory of Diabetes Immunology, Ministry of Education, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China
- Jing Ni
- Xuehong Zhang
- DOI
- https://doi.org/10.1097/CM9.0000000000003108
- Journal volume & issue
-
Vol. 137,
no. 11
pp. 1372 – 1374
Abstract
No abstracts available.